OTC Watch

All stocks / BICX

BioCorRx Inc. BICX

BioCorRx (BICX): shares outstanding up 25% in a year and the latest annual figures in plain language. Each fact links to its SEC filing.

DilutionEstimated float OTCIDCalifornia, USA
Live quote on OTC Markets

Market listing

Full name
BIOCORRX INC
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 16
Website
www.biocorrx.com
Source: Stockwatch, 2026-11-17

News headlines

BioCorRx Inc. to Present at the Life Sciences Virtual Investor Forum December 11th
2025-12-10 08:35 ยท News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$797,244
Net loss
($3,440,146)
What it means

It spends more than it earns

Under strain

Customers paid it $797,244 in the year. It lost $3.4 million. For every $1 that came in, about $5.32 went out.

The report says
Cash and cash equivalents
$139,360
Net cash used in operating activities
($2,298,291)
What it means

The cash could run out soon

Under strain

It had $139,360 in the bank and used about $191,524 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$2,147,212
Total liabilities
$13,674,200
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $2.1 million. Its debts and unpaid bills add up to $13.7 million. That is about $6.37 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Dilution2026-11-16

Shares outstanding rose from 24,489,311 (2025-12-31) to 30,643,140 (2026-11-16), up 25%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-11-16

Estimated float about 30,643,140 shares as of 2026-11-16: 30,643,140 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2025-12-31
24.5M
2026-03-27
26.4M
2026-03-31
28.9M
2026-05-14
29.1M
2026-06-30
29.7M
2026-08-14
29.8M
2026-09-30
30.5M
2026-11-16
30.6M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 10-QFORM 10-Q
2026-09-04 8-KFORM 8-K
2026-08-14 10-QFORM 10-Q
2026-05-15 10-QFORM 10-Q
2026-04-02 8-KFORM 8-K
2026-03-31 10-KFORM 10-K

Common questions about BICX

Does BICX file reports with the SEC?

Yes. BioCorRx files with the SEC under company number 0001443863. The most recent filing we hold is a 10-Q dated 2026-11-16.

Source record

How many BICX shares are outstanding?

30,643,140 shares as of 2026-11-16, as reported to the SEC. That is up 25% from 24,489,311 on 2025-12-31.

Source record

Has BICX filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is BioCorRx making money?

Customers paid it $797,244 in the year. It lost $3.4 million. For every $1 that came in, about $5.32 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record